Literature DB >> 7975862

Comparison of structural proteins among antigenically different Japanese encephalitis virus strains.

H Hasegawa1, M Yoshida, S Fujita, Y Kobayashi.   

Abstract

Based on the reactivities of monoclonal antibodies, we have reported previously that 25 Japanese encephalitis virus (JEV) strains fell into five antigenic groups: Nakayama, Beijing-1, Kamiyama, 691004 and Muar. In the present study, we compared the nucleotide and deduced amino acid sequences of the structural proteins of these strains. Four strains, Nakayama-RFVL, Beijing-1, Kamiyama and 691004, shared > 96.4% identity in the nucleotide sequence and > 94.7% identity in the amino acid sequence. However, the Muar strain had only an 80.3-87.7% homology for nucleotides and an 85.7-93.5% homology for amino acids, compared with the other four strains. The following strain-specific amino acid differences were found in the envelope protein: two in Nakayama-RFVL; three in Beijing-1; one in Kamiyama; five in 691004; 42 in Muar. These findings showed that the Muar strain was the most structurally different from the other four strains, and that it would be possible to compare antigenic differences among the JEV strains by using monoclonal antibodies which showed different specificities.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7975862     DOI: 10.1016/0264-410x(94)90294-1

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  11 in total

1.  A Japanese encephalitis virus genotype 5 molecular clone is highly neuropathogenic in a mouse model: impact of the structural protein region on virulence.

Authors:  Mélissanne de Wispelaere; Marie-Pascale Frenkiel; Philippe Desprès
Journal:  J Virol       Date:  2015-03-18       Impact factor: 5.103

2.  Origin and evolution of Japanese encephalitis virus in southeast Asia.

Authors:  Tom Solomon; Haolin Ni; David W C Beasley; Miquel Ekkelenkamp; Mary Jane Cardosa; Alan D T Barrett
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

Review 3.  Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease.

Authors:  Nagendra R Hegde; Milind M Gore
Journal:  Hum Vaccin Immunother       Date:  2017-02-22       Impact factor: 3.452

4.  Molecular epidemiology of Japanese encephalitis virus circulating in South Korea, 1983-2005.

Authors:  Seok-Min Yun; Jung Eun Cho; Young-Ran Ju; Su Yeon Kim; Jungsang Ryou; Myung Guk Han; Woo-Young Choi; Young Eui Jeong
Journal:  Virol J       Date:  2010-06-14       Impact factor: 4.099

5.  Characterization of two Japanese encephalitis virus strains isolated in Thailand.

Authors:  A Ali; A Igarashi; L R Paneru; F Hasebe; K Morita; M Takagi; W Suwonkerd; Y Tsuda; Y Wada
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

6.  Genotype v Japanese encephalitis virus is emerging.

Authors:  Ming-Hua Li; Shi-Hong Fu; Wei-Xin Chen; Huan-Yu Wang; Yu-Hong Guo; Qi-Yong Liu; Yi-Xing Li; Hui-Ming Luo; Wa Da; Dun Zhu Duo Ji; Xiu-Min Ye; Guo-Dong Liang
Journal:  PLoS Negl Trop Dis       Date:  2011-07-05

7.  Isolation and genetic characterization of Japanese encephalitis virus from equines in India.

Authors:  Baldev R Gulati; Harisankar Singha; Birendra K Singh; Nitin Virmani; Sanjay Kumar; Raj K Singh
Journal:  J Vet Sci       Date:  2012-06       Impact factor: 1.672

8.  European Aedes albopictus and Culex pipiens Are Competent Vectors for Japanese Encephalitis Virus.

Authors:  Mélissanne de Wispelaere; Philippe Desprès; Valérie Choumet
Journal:  PLoS Negl Trop Dis       Date:  2017-01-13

Review 9.  Japanese encephalitis: the virus and vaccines.

Authors:  Sang-Im Yun; Young-Min Lee
Journal:  Hum Vaccin Immunother       Date:  2013-10-25       Impact factor: 3.452

10.  Effects of the Japanese Encephalitis Virus Genotype V-Derived Sub-Viral Particles on the Immunogenicity of the Vaccine Characterized by a Novel Virus-Like Particle-Based Assay.

Authors:  Sarah Honjo; Michiaki Masuda; Tomohiro Ishikawa
Journal:  Vaccines (Basel)       Date:  2019-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.